Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
David Qualls MD

David Qualls MD

Medical Oncologist, Lymphoma Division, Dana-Farber Cancer Institute, Boston, Massachusetts

David Qualls is a medical oncologist in the Lymphoma Division at Dana-Farber Cancer Institute. His research is focused on improving outcomes for patients with aggressive B-cell lymphomas using clinical trials and real-world studies.

Disclosures

Dr. Qualls is on the advisory board and does consulting for Genmab.

Recent Contributions to PracticeUpdate:

  1. Autologous Transplant vs CAR T-Cell Therapy in Patients With DLBCL in Complete Remission

Most Read This Week

Recently Updated